Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

The role of HLA-DP mismatches and donor specific HLA-DP antibodies in kidney transplantation: a case series.

Daniëls L, Claas FHJ, Kramer CSM, Senev A, Vanden Driessche M, Emonds MP, Van Laecke S, Hellemans R, Abramowicz D, Naesens M.

Transpl Immunol. 2020 Mar 16:101287. doi: 10.1016/j.trim.2020.101287. [Epub ahead of print]

PMID:
32194154
2.

Bortezomib for autoimmune hemolytic anemia after intestinal transplantation.

Knops N, Emonds MP, Herman J, Levtchenko E, Mekahli D, Pirenne J, Van Geet C, Dierickx D.

Pediatr Transplant. 2020 Mar 12:e13700. doi: 10.1111/petr.13700. [Epub ahead of print]

PMID:
32166874
3.

Assessing the Complex Causes of Kidney Allograft Loss.

Van Loon E, Senev A, Lerut E, Coemans M, Callemeyn J, Van Keer JM, Daniëls L, Kuypers D, Sprangers B, Emonds MP, Naesens M.

Transplantation. 2020 Feb 20. doi: 10.1097/TP.0000000000003192. [Epub ahead of print]

PMID:
32091487
4.

Defining Polysaccharide Antibody Deficiency: Measurement of Anti-Pneumococcal Antibodies and Anti-Salmonella typhi Antibodies in a Cohort of Patients with Recurrent Infections.

Bucciol G, Schaballie H, Schrijvers R, Bosch B, Proesmans M, De Boeck K, Boon M, Vermeulen F, Lorent N, Dillaerts D, Kantsø B, Jørgensen CS, Emonds MP, Bossuyt X, Moens L, Meyts I.

J Clin Immunol. 2020 Jan;40(1):105-113. doi: 10.1007/s10875-019-00691-8. Epub 2019 Nov 8.

PMID:
31705452
5.

Antibodies against ARHGDIB and ARHGDIB gene expression associate with kidney allograft outcome.

Senev A, Otten HG, Kamburova EG, Callemeyn J, Lerut E, Van Sandt V, Kuypers D, Emonds MP, Naesens M.

Transplantation. 2019 Oct 14. doi: 10.1097/TP.0000000000003005. [Epub ahead of print]

PMID:
31651716
6.

Long-term outcome of cardiac allograft vasculopathy: Importance of the International Society for Heart and Lung Transplantation angiographic grading scale.

Van Keer JM, Van Aelst LNL, Rega F, Droogne W, Voros G, Meyns B, Vanhaecke J, Emonds MP, Janssens S, Naesens M, Van Cleemput J.

J Heart Lung Transplant. 2019 Nov;38(11):1189-1196. doi: 10.1016/j.healun.2019.08.005. Epub 2019 Aug 10.

PMID:
31543298
7.

Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunction.

Sacreas A, Taupin JL, Emonds MP, Daniëls L, Van Raemdonck DE, Vos R, Verleden GM, Vanaudenaerde BM, Roux A, Verleden SE; and the Leuven Lung Transplant Group.

Eur Respir J. 2019 Nov 7;54(5). pii: 1900847. doi: 10.1183/13993003.00847-2019. Print 2019 Nov.

PMID:
31439680
8.

HLA Class II Antibodies at the Time of Kidney Transplantation and Cardiovascular Outcome: A Retrospective Cohort Study.

Malfait T, Emonds MP, Daniëls L, Nagler EV, Van Biesen W, Van Laecke S.

Transplantation. 2020 Apr;104(4):823-834. doi: 10.1097/TP.0000000000002889.

PMID:
31369517
9.

Are we underestimating reverse TRALI?

De Clippel D, Emonds MP, Compernolle V.

Transfusion. 2019 Sep;59(9):2788-2793. doi: 10.1111/trf.15431. Epub 2019 Jun 26.

PMID:
31241780
10.

The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation.

Gielis EM, Ledeganck KJ, Dendooven A, Meysman P, Beirnaert C, Laukens K, De Schrijver J, Van Laecke S, Van Biesen W, Emonds MP, De Winter BY, Bosmans JL, Del Favero J, Abramowicz D.

Nephrol Dial Transplant. 2019 May 18. pii: gfz091. doi: 10.1093/ndt/gfz091. [Epub ahead of print]

PMID:
31106364
11.

Specificity, strength, and evolution of pretransplant donor-specific HLA antibodies determine outcome after kidney transplantation.

Senev A, Lerut E, Van Sandt V, Coemans M, Callemeyn J, Sprangers B, Kuypers D, Emonds MP, Naesens M.

Am J Transplant. 2019 Nov;19(11):3100-3113. doi: 10.1111/ajt.15414. Epub 2019 Jun 19.

PMID:
31062492
12.

Occurrence of Diabetic Nephropathy After Renal Transplantation Despite Intensive Glycemic Control: An Observational Cohort Study.

Coemans M, Van Loon E, Lerut E, Gillard P, Sprangers B, Senev A, Emonds MP, Van Keer J, Callemeyn J, Daniëls L, Sichien J, Verbeke G, Kuypers D, Mathieu C, Naesens M.

Diabetes Care. 2019 Apr;42(4):625-634. doi: 10.2337/dc18-1936. Epub 2019 Feb 14.

PMID:
30765434
13.

Histological picture of ABMR without HLA-DSA: Temporal dynamics of effector mechanisms are relevant in disease reclassification.

Senev A, Callemeyn J, Lerut E, Emonds MP, Naesens M.

Am J Transplant. 2019 Mar;19(3):954-955. doi: 10.1111/ajt.15234. Epub 2019 Jan 24. No abstract available.

14.

Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay.

Gielis EM, Beirnaert C, Dendooven A, Meysman P, Laukens K, De Schrijver J, Van Laecke S, Van Biesen W, Emonds MP, De Winter BY, Bosmans JL, Del Favero J, Abramowicz D, Ledeganck KJ.

PLoS One. 2018 Dec 6;13(12):e0208207. doi: 10.1371/journal.pone.0208207. eCollection 2018.

15.

Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.

Senev A, Coemans M, Lerut E, Van Sandt V, Daniëls L, Kuypers D, Sprangers B, Emonds MP, Naesens M.

Am J Transplant. 2019 Mar;19(3):763-780. doi: 10.1111/ajt.15074. Epub 2018 Sep 28.

16.

Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015.

Coemans M, Süsal C, Döhler B, Anglicheau D, Giral M, Bestard O, Legendre C, Emonds MP, Kuypers D, Molenberghs G, Verbeke G, Naesens M.

Kidney Int. 2018 Nov;94(5):964-973. doi: 10.1016/j.kint.2018.05.018. Epub 2018 Jul 24.

PMID:
30049474
17.

The clinical significance of epitope mismatch load in kidney transplantation: A multicentre study.

Daniëls L, Naesens M, Bosmans JL, Abramowicz D, Nagler E, Van Laecke S, Peeters P, Kuypers D, Emonds MP.

Transpl Immunol. 2018 Oct;50:55-59. doi: 10.1016/j.trim.2018.06.006. Epub 2018 Jun 15.

PMID:
29908316
18.

Worldwide policies on epilepsy and blood donation: a survey among blood services.

Kellens A, De Buck E, Emonds MP, Vandekerckhove P, Lagae L.

Vox Sang. 2018 Feb;113(2):104-109. doi: 10.1111/vox.12618. Epub 2018 Jan 4.

PMID:
29314064
19.

Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity.

Meysman P, De Neuter N, Bartholomeus E, Elias G, Van den Bergh J, Emonds MP, Haasnoot GW, Heynderickx S, Wens J, Michels NR, Lambert J, Lion E, Claas FHJ, Goossens H, Smits E, Van Damme P, Van Tendeloo V, Beutels P, Suls A, Mortier G, Laukens K, Ogunjimi B.

Immunogenetics. 2018 Jun;70(6):363-372. doi: 10.1007/s00251-017-1047-x. Epub 2017 Dec 1.

PMID:
29196796
20.

Is it safe for people with epilepsy to donate blood? A systematic review.

Kellens A, De Buck E, Emonds MP, Vandekerckhove P, Lagae L.

Epilepsy Res. 2018 Jan;139:143-149. doi: 10.1016/j.eplepsyres.2017.11.002. Epub 2017 Nov 23.

PMID:
29174496
21.

Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation.

Verleden SE, Vanaudenaerde BM, Emonds MP, Van Raemdonck DE, Neyrinck AP, Verleden GM, Vos R.

Eur Respir J. 2017 Nov 16;50(5). pii: 1701248. doi: 10.1183/13993003.01248-2017. Print 2017 Nov.

22.

Prediction of delayed graft function using different scoring algorithms: A single-center experience.

Michalak M, Wouters K, Fransen E, Hellemans R, Van Craenenbroeck AH, Couttenye MM, Bracke B, Ysebaert DK, Hartman V, De Greef K, Chapelle T, Roeyen G, Van Beeumen G, Emonds MP, Abramowicz D, Bosmans JL.

World J Transplant. 2017 Oct 24;7(5):260-268. doi: 10.5500/wjt.v7.i5.260.

23.

Fifth Percentile Cutoff Values for Antipneumococcal Polysaccharide and Anti-Salmonella typhi Vi IgG Describe a Normal Polysaccharide Response.

Schaballie H, Bosch B, Schrijvers R, Proesmans M, De Boeck K, Boon MN, Vermeulen F, Lorent N, Dillaerts D, Frans G, Moens L, Derdelinckx I, Peetermans W, Kantsø B, Jørgensen CS, Emonds MP, Bossuyt X, Meyts I.

Front Immunol. 2017 May 12;8:546. doi: 10.3389/fimmu.2017.00546. eCollection 2017.

24.

Immunological diversity in phenotypes of chronic lung allograft dysfunction: a comprehensive immunohistochemical analysis.

Vandermeulen E, Lammertyn E, Verleden SE, Ruttens D, Bellon H, Ricciardi M, Somers J, Bracke KR, Van Den Eynde K, Tousseyn T, Brusselle GG, Verbeken EK, Verschakelen J, Emonds MP, Van Raemdonck DE, Verleden GM, Vos R, Vanaudenaerde BM.

Transpl Int. 2017 Feb;30(2):134-143. doi: 10.1111/tri.12882. Epub 2016 Dec 8.

25.

Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis.

Vandermeulen E, Verleden SE, Bellon H, Ruttens D, Lammertyn E, Claes S, Vandooren J, Ugarte-Berzal E, Schols D, Emonds MP, Van Raemdonck DE, Opdenakker G, Verleden GM, Vos R, Vanaudenaerde BM.

Transpl Immunol. 2016 Sep;38:27-32. doi: 10.1016/j.trim.2016.08.004. Epub 2016 Aug 22.

PMID:
27561239
26.

Epitope analysis of DQ6-reactive antibodies in sera from a DQ6-positive transplant candidate sensitized during pregnancy.

Daniëls L, Emonds MP, Bosmans JL, Marrari M, Duquesnoy RJ.

Transpl Immunol. 2016 Sep;38:15-8. doi: 10.1016/j.trim.2016.07.004. Epub 2016 Jul 26.

PMID:
27473667
27.

Donor-specific antibodies require preactivated immune system to harm renal transplant.

Süsal C, Döhler B, Ruhenstroth A, Morath C, Slavcev A, Fehr T, Wagner E, Krüger B, Rees M, Balen S, Živčić-Ćosić S, Norman DJ, Kuypers D, Emonds MP, Pisarski P, Bösmüller C, Weimer R, Mytilineos J, Scherer S, Tran TH, Gombos P, Schemmer P, Zeier M, Opelz G; A Collaborative Transplant Study Report.

EBioMedicine. 2016 Jul;9:366-371. doi: 10.1016/j.ebiom.2016.06.006. Epub 2016 Jun 5.

28.

The Leuven Immunomodulatory Protocol Promotes T-Regulatory Cells and Substantially Prolongs Survival After First Intestinal Transplantation.

Ceulemans LJ, Braza F, Monbaliu D, Jochmans I, De Hertogh G, Du Plessis J, Emonds MP, Kitade H, Kawai M, Li Y, Zhao X, Koshiba T, Sprangers B, Brouard S, Waer M, Pirenne J.

Am J Transplant. 2016 Oct;16(10):2973-2985. doi: 10.1111/ajt.13815. Epub 2016 May 12.

29.

Intrauterine transfusion for fetal anemia due to red blood cell alloimmunization: 14 years experience in Leuven.

Pasman SA, Claes L, Lewi L, Van Schoubroeck D, Debeer A, Emonds M, Geuten E, De Catte L, Devlieger R.

Facts Views Vis Obgyn. 2015;7(2):129-36.

30.

Proteinuria as a Noninvasive Marker for Renal Allograft Histology and Failure: An Observational Cohort Study.

Naesens M, Lerut E, Emonds MP, Herelixka A, Evenepoel P, Claes K, Bammens B, Sprangers B, Meijers B, Jochmans I, Monbaliu D, Pirenne J, Kuypers DR.

J Am Soc Nephrol. 2016 Jan;27(1):281-92. doi: 10.1681/ASN.2015010062. Epub 2015 Jul 7.

31.

Comparison of methods for in-house screening of HLA-B*57:01 to prevent abacavir hypersensitivity in HIV-1 care.

De Spiegelaere W, Philippé J, Vervisch K, Verhofstede C, Malatinkova E, Kiselinova M, Trypsteen W, Bonczkowski P, Vogelaers D, Callens S, Ruelle J, Kabeya K, De Wit S, Van Acker P, Van Sandt V, Emonds MP, Coucke P, Sermijn E, Vandekerckhove L.

PLoS One. 2015 Apr 15;10(4):e0123525. doi: 10.1371/journal.pone.0123525. eCollection 2015.

32.

Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society.

Baron F, Zachée P, Maertens J, Kerre T, Ory A, Seidel L, Graux C, Lewalle P, Van Gelder M, Theunissen K, Willems E, Emonds MP, De Becker A, Beguin Y.

J Hematol Oncol. 2015 Feb 6;8:4. doi: 10.1186/s13045-014-0098-9.

33.

Value of allohaemagglutinins in the diagnosis of a polysaccharide antibody deficiency.

Schaballie H, Vermeulen F, Verbinnen B, Frans G, Vermeulen E, Proesmans M, De Vreese K, Emonds MP, De Boeck K, Moens L, Picard C, Bossuyt X, Meyts I.

Clin Exp Immunol. 2015 May;180(2):271-9. doi: 10.1111/cei.12571.

34.

RHD variants in Flanders, Belgium.

Van Sandt VS, Gassner C, Emonds MP, Legler TJ, Mahieu S, Körmöczi GF.

Transfusion. 2015 Jun;55(6 Pt 2):1411-7. doi: 10.1111/trf.12947. Epub 2014 Nov 21.

PMID:
25413499
35.

Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy.

De Clippel D, Baeten M, Torfs A, Emonds MP, Feys HB, Compernolle V, Vandekerckhove P.

Transfusion. 2014 Dec;54(12):3036-42. doi: 10.1111/trf.12727. Epub 2014 May 27.

PMID:
24863861
36.

The phenotype and genotype of rheumatoid arthritis in the Democratic Republic of Congo.

Malemba JJ, Mbuyi-Muamba JM, Mukaya J, Bossuyt X, Emonds MP, Deiteren K, Westhovens R, Verschueren P.

Arthritis Res Ther. 2013 Aug 19;15(4):R89. doi: 10.1186/ar4269.

37.

Heterozygous α1-antitrypsin Z allele mutation in presumed healthy donor livers used for transplantation.

Roelandt P, Dobbels P, Komuta M, Corveleyn A, Emonds MP, Roskams T, Aerts R, Monbaliu D, Libbrecht L, Laleman W, Verslype C, Van Steenbergen W, van der Merwe S, Pirenne J, Nevens F, Cassiman D.

Eur J Gastroenterol Hepatol. 2013 Nov;25(11):1335-9. doi: 10.1097/MEG.0b013e32836171c4.

PMID:
23660934
38.

Amniopatch for iatrogenic rupture of the fetal membranes.

Deprest J, Emonds MP, Richter J, DeKoninck P, Van Mieghem T, Van Schoubroeck D, Devlieger R, De Catte L, Lewi L.

Prenat Diagn. 2011 Jul;31(7):661-6. doi: 10.1002/pd.2780. Epub 2011 Jun 8. Review.

PMID:
21656529
39.

[Amniopatch to treat iatrogenic rupture of the fetal membranes].

Deprest J, Van Mieghem T, Emonds MP, Richter J, De Koninck P, Zia S, Van Keirsbilck J, Sandaite I, Olde Damink L, Lewi L.

Gynecol Obstet Fertil. 2011 Jun;39(6):378-82. doi: 10.1016/j.gyobfe.2011.04.010. Epub 2011 May 18. French.

PMID:
21596607
40.

Eight new alleles found in Flanders (Belgium), including the HLA-DRB1*12:24N allele.

Van Sandt VS, Mahieu S, Emonds MP.

Tissue Antigens. 2011 Jul;78(1):45-8. doi: 10.1111/j.1399-0039.2011.01660.x. Epub 2011 Apr 4.

PMID:
21457147
41.

Immediate posttransplantation cotrimoxazole-induced immune thrombocytopenia.

Caluwé R, Van Laecke S, Emonds MP, Peeters P, Vanholder R.

Am J Transplant. 2010 Apr;10(4):943-6. doi: 10.1111/j.1600-6143.2010.03028.x. Epub 2010 Feb 25.

42.

Plasma selenium levels in healthy blood bank donors in the central-eastern part of Belgium.

Van Cauwenbergh R, Robberecht H, Van Vlaslaer V, De Smet A, Emonds MP, Hermans N.

J Trace Elem Med Biol. 2007;21(4):225-33. Epub 2007 Aug 6.

PMID:
17980813
43.

Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection?

Lerut E, Van Damme B, Noizat-Pirenne F, Emonds MP, Rouger P, Vanrenterghem Y, Pirenne J, Ansart-Pirenne H.

Transfusion. 2007 Jan;47(1):28-40.

PMID:
17207227
44.

Primary sclerosing cholangitis in two brothers: report of a family with special emphasis on molecular HLA and MICA genotyping.

Van Steenbergen W, De Goede E, Emonds MP, Reinders J, Tilanus M, Fevery J.

Eur J Gastroenterol Hepatol. 2005 Jul;17(7):767-71.

PMID:
15947556
45.

Capillary deposition of complement C4d and C3d in pediatric renal allograft biopsies.

Herman J, Lerut E, Van Damme-Lombaerts R, Emonds MP, Van Damme B.

Transplantation. 2005 May 27;79(10):1435-40.

PMID:
15912116
46.

Successful patching of iatrogenic rupture of the fetal membranes.

Lewi L, Van Schoubroeck D, Van Ranst M, Bries G, Emonds MP, Arabin B, Welch R, Deprest J.

Placenta. 2004 Apr;25(4):352-6.

PMID:
15028428
47.

Persistent polyclonal B-cell lymphocytosis.

Ide L, Dekoninck A, Verburgh E, Goossens W, Brusselmans C, Boeckx N, Emonds MP, Vandekerckhove P.

Acta Clin Belg. 2002 Jan-Feb;57(1):31-3.

PMID:
12017755
48.

Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature.

Itterbeek P, Vandenberghe P, Nevens F, Fevery J, Aerts R, Yap SH, Demuynck H, Fourneau I, Koshiba T, Emonds MP, Roskams T, Boogaerts M, Pirenne J.

Transpl Int. 2002 Mar;15(2-3):117-23. Epub 2002 Mar 5. Review.

PMID:
11935168
49.

Complete freedom from rejection after intestinal transplantation using a new tolerogenic protocol combined with low immunosuppression.

Pirenne J, Koshiba T, Geboes K, Emonds MP, Ferdinande P, Hiele M, Nevens F, Waer M.

Transplantation. 2002 Mar 27;73(6):966-8.

PMID:
11923701
50.

Supplemental Content

Loading ...
Support Center